Business

22nd Century Group to Announce Second Quarter 2024 Results on August 13, 2024

Mocksville, North Carolina--(Newsfile Corp. - August 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm

article22nd Century Group, IncAugust 6, 20244/company/22nd-century-group-inc/news/22nd-century-group-to-announce-second-quarter-2024-results-on-august-13-2024
22nd Century Group to Announce Second Quarter 2024 Results on August 13, 2024

About this update from 22nd Century Group, Inc

[{"type":"text","content":"Mocksville, North Carolina--(Newsfile Corp. - August 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, will host a webcast on Tuesday, August 13, 2024, at 8:00 AM ET to discuss its 2024 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day.\nDuring the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.\nThe live and archived webcast will be accessible on the Events web page in the Company's Investor Relations section of the website, at https://ir.xxiicentury.com/events. Please access the website at least 15 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.\nAbout 22nd Century Group, Inc.\n22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction by offering tobacco products with 95% less nicotine, designed to improve health and wellness by helping smokers smoke less. Backed by comprehensive and extensively patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, the Company has pioneered the development of high-yield, proprietary reduced nicotine content (RNC) tobacco plants and clinically validated RNC cigarette products. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. The Company is a subsequent participating manufacturer under the Master Settlement Agreement (\"MSA\") and vertically integrated for the production of both its own products and contract manufacturing operations (\"CMO\"), which consist primarily of branded filtered cigars and conventional cigarettes.\nLearn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.\nLearn more about VLN® at tryvln.com.\nCautionary Note Regarding Forward-Looking Statements\nExcept for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-Looking statements typically contain terms such as \"anticipate,\" \"believe,\" ...

More updates from 22nd Century Group, Inc